LogicBio

1 stories about LogicBio
נאסד"ק וול סטריט

LogicBio Therapeutics Underperforms with $70 Million Nasdaq IPO

21.10.18|Lilach Baumer
Co-founded by Israel-born Adi Barzel, LogicBio develops genome-editing treatments for rare diseases